Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study.

Jennifer TaherChloe MightonSunakshi ChowdharySelina CasalinoErika FrangioneSaranya ArnoldoErin BearssAlexandra BinnieYvonne BombardBjug BorgundvaagHoward ChertkowMarc ClausenLuke DevineHanna FaghfourySteven Marc FriedmanAnne-Claude GingrasZeeshan KhanTony MazzulliAllison McGeerShelley L McLeodTrevor J PughDavid RichardsonJared SimpsonSeth SternLisa StrugAhmed TaherJordan Lerner- Ellis

Published in: BMJ open (2021)

This study was approved by Clinical Trials Ontario Streamlined Ethics Review System (CTO Project ID: 3302) and the research ethics boards at participating hospitals. Study findings will be disseminated through peer-reviewed publications, conference presentations and end-users.

Keyphrases

clinical trial
healthcare
public health
coronavirus disease
sars cov
primary care
randomized controlled trial
quality improvement
big data
machine learning
open label